Inventor

DICKNEITE GERHARD

DE27 patents

⚠️ This page may combine multiple inventors who share the name “DICKNEITE GERHARD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DICKNEITE GERHARD

HOECHST AG

Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives

Use of the diterpene derivative forskolin for immunostimulation

1,3-thiazoles and their use as immunomodulators

Pharmaceuticals, phosphorus-containing 2-isoxazolines and isoxazoles contained therein

Immunosuppressive chromone alkaloid

Use of cephem compounds as immunomodulators

BEHRINGWERKE AG

Manumycin derivatives and the use thereof

Amidinophenylalanine derivatives, process for their preparation, their use and compositions containing them

Use of Lycorine as an immunosuppressor

Use of VWF-containing concentrates as a therapy which is employed in combination with antithrombotic and fibrinolytic therapy

Use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases

Use of 15-deoxyspergualine as a pharmaceutical

AVENTIS BEHRING GMBH

Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura

Pharmaceutical preparation for the treatment of inflammatory processes

Transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding

Pharmaceutical preparation for the treatment of inflammatory processes

CSL BEHRING GMBH

Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces

Use of C1-inhibitor for the treatment of secondary edema of the central nervous system

von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes

DICKNEITE GERHARD

Synergistic therapeutic use of Prothrombin Complex Concentrates with FVIII concentrates

von Willebrand factor or factor VIII and von Willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes

Synergistic therapeutic use of prothrombin complex concentrates with FVIII concentrates

HOECHST LAB

Glycosylated prodrugs, their method of preparation and their uses

ZLB BEHRING GMBH

Tissue glue with improved antiadhesive properties

ZEITLER STEFAN

Factor XII inhibitors for the administration with medical procedures comprising contact with artificial surfaces

NAHRENDORF MATTHIAS

Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs

CSL Behring Lengnau AG

Modified von Willebrand factor having improved half-life